What oral antibiotic treatment is appropriate for a vaginal swab positive for Enterococcus faecalis, Lactobacillus species, and Prevotella bivia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Vaginal Swab Positive for Enterococcus faecalis, Lactobacillus spp, & Prevotella bivia

Metronidazole 500 mg orally twice daily for 7 days is the recommended treatment for a vaginal swab showing Prevotella bivia, as this organism is commonly associated with bacterial vaginosis (BV). 1 The presence of Lactobacillus species is actually normal vaginal flora, while Enterococcus faecalis and Prevotella bivia suggest dysbiosis consistent with BV.

Diagnostic Considerations

Before initiating treatment, confirm that the patient meets clinical criteria for BV, which requires three of the following:

  • Homogeneous, white, non-inflammatory discharge adhering to vaginal walls
  • Presence of clue cells on microscopic examination
  • Vaginal fluid pH greater than 4.5
  • Fishy odor of vaginal discharge before or after addition of 10% KOH (whiff test) 2

Prevotella bivia is a key anaerobic organism associated with BV and treatment failure 3, making appropriate antibiotic therapy essential.

Treatment Options

First-line Treatment:

  • Metronidazole 500 mg orally twice daily for 7 days 1

Alternative Regimens:

  • Metronidazole 2 g orally in a single dose (lower cure rate of 84% vs 95% for 7-day regimen) 2
  • Clindamycin 300 mg orally twice daily for 7 days 1
  • Clindamycin cream 2%, one full applicator (5 g) intravaginally at bedtime for 7 days 1
  • Metronidazole gel 0.75%, one full applicator (5 g) intravaginally twice daily for 5 days 1

Important Precautions

  • Patients must avoid alcohol during metronidazole treatment and for 24 hours afterward to prevent disulfiram-like reactions 1
  • Clindamycin cream is oil-based and may weaken latex condoms and diaphragms 1
  • Follow-up visits are unnecessary if symptoms resolve 2

Management of Recurrence

Recurrence is common, with 50-80% of women experiencing recurrence within a year of treatment 4. This may be due to:

  • Persistence of biofilms protecting BV-causing bacteria 5
  • Higher abundance of Prevotella before treatment and persistence of Gardnerella after treatment 3
  • Failure of beneficial Lactobacillus species to recolonize the vagina 4

For recurrent BV, use an extended course of metronidazole (500 mg twice daily for 10-14 days) or metronidazole vaginal gel 0.75% for 10 days, followed by twice weekly for 3-6 months 5.

Partner Treatment

Routine treatment of sex partners is not recommended by the CDC, as clinical trials indicate that partner treatment does not affect a woman's response to therapy or likelihood of relapse/recurrence 1. However, some studies suggest that women with untreated regular sexual partners may be more likely to experience recurrence than those with no partner or those whose partner received treatment 3.

Special Considerations

  • If the patient is pregnant, metronidazole 250 mg orally three times daily for 7 days is recommended 1
  • Before surgical procedures, treating BV may reduce post-operative infectious complications 1
  • If the patient has an allergy or intolerance to metronidazole, clindamycin is the preferred alternative 2

References

Guideline

Bacterial Vaginosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Characterization and Treatment of Recurrent Bacterial Vaginosis.

Journal of women's health (2002), 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.